Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
RESEARCH TOOLSreports
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $1.22B. The enterprise value is $689.90M.
Market Cap$1.22B
Enterprise Value$689.90M
Share Statistics
Kestra Medical Technologies Ltd. has 51,449,055 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,449,055
Owned by Insiders1.16%
Owned by Institutions68.86%
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is -655.61%.
Return on Equity (ROE)0.45
Return on Assets (ROA)-2.05
Return on Invested Capital (ROIC)-655.61%
Return on Capital Employed (ROCE)-6.55
Revenue Per Employee199.38K
Profits Per Employee-379.38K
Employee Count300
Asset Turnover0.61
Inventory Turnover8.34
Valuation Ratios
The current PE Ratio of Kestra Medical Technologies Ltd. is ―. Kestra Medical Technologies Ltd.’s PEG ratio is -0.69.
PE Ratio―
PS Ratio38.89
PB Ratio-5.17
Price to Fair Value-5.17
Price to FCF-12.76
Price to Operating Cash Flow-15.52
PEG Ratio-0.69
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 59.81M and earned -113.81M in profits. Earnings per share was -5.13.
Revenue59.81M
Gross Profit24.21M
Operating Income-106.38M
Pretax Income-113.68M
Net Income-113.81M
EBITDA-97.98M
Earnings Per Share (EPS)-5.13
Cash Flow
In the last 12 months, operating cash flow was -68.36M and capital expenditures -20.27M, giving a free cash flow of -88.63M billion.
Operating Cash Flow-68.36M
Free Cash Flow-88.63M
Free Cash Flow per Share-1.72
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change18.82%
50-Day Moving Average17.30
200-Day Moving Average―
Relative Strength Index (RSI)79.21
Average Volume (3m)273.67K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Apr 20, 2026, After Close (Confirmed).
Last Earnings DateSep 11, 2025
Next Earnings DateApr 20, 2026
Ex-Dividend Date―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 0.45, with Debt / Equity ratio of 1.68%
Current Ratio0.45
Quick Ratio0.35
Debt to Market Cap0.04
Net Debt to EBITDA-0.48
Interest Coverage Ratio-13.65
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 135.00K in taxes.
Income Tax135.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -14.66, with an EV/FCF ratio of -13.20.
EV to Sales40.22
EV to EBITDA-14.66
EV to Free Cash Flow-13.20
EV to Operating Cash Flow-15.49
Balance Sheet
Kestra Medical Technologies Ltd. has $201.21M in cash and marketable securities with $3.10M in debt, giving a net cash position of $198.11M billion.
Cash & Marketable Securities$201.21M
Total Debt$3.10M
Net Cash$198.11M
Net Cash Per Share$3.85
Tangible Book Value Per Share-$4.23
Margins
Gross margin is 39.56%, with operating margin of -305.83%, and net profit margin of -338.39%.
Gross Margin39.56%
Operating Margin-305.83%
Pretax Margin-338.30%
Net Profit Margin-338.39%
EBITDA Margin-274.34%
EBIT Margin-315.91%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $25.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$25.67
Price Target Upside2.93% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast83.78%
EPS Growth Forecast-25.37%